Department of Cardiology, Jikei University School of Medicine, Minato-ku, Tokyo, Japan.
Am Heart J. 2010 Aug;160(2):337-45. doi: 10.1016/j.ahj.2010.05.025.
The elimination of transient pulmonary vein (PV) reconduction (dormant PV conduction) revealed by adenosine in addition to PV isolation reduced the atrial fibrillation (AF) recurrence after catheter ablation. The dormant PV conduction is induced in approximately half of the AF patients that undergo PV isolation. The present study compared the clinical outcome of AF ablation in patients whose dormant PV conduction was eliminated by additional radiofrequency applications with the outcome in patients without dormant conduction.
A total of 233 consecutive patients (206 male, 54.2 +/- 10.1 years) that underwent AF ablation were included in the present study. Dormant PV conduction was induced by the administration of adenosine triphosphate after PV isolation and was eliminated by supplemental radiofrequency application. All patients were followed up for >12 months (mean 903 days) after the first ablation.
Following PV isolation, dormant PV conduction was induced in 139 (59.7%) of 233 patients and was successfully eliminated in 98% (223/228) of those in the first ablation procedure. After the first procedure, 63.9% (149/233) of patients were free from AF recurrence events. The success rates of a single or final AF ablation in patients with the appearance of the dormant PV conduction were similar to those of patients without dormant conduction (P = .69 and P = .69, respectively).
Dormant PV conduction was induced in over half of the patients with AF. After the elimination of adenosine triphosphate-induced reconnection, the clinical outcome of patients with the dormant PV conduction was equivalent to that of patients without conduction.
腺苷除了隔离肺静脉(PV)之外,还能消除瞬时 PV 再传导(潜伏性 PV 传导),从而降低导管消融后心房颤动(AF)的复发率。大约有一半接受 PV 隔离的 AF 患者会出现潜伏性 PV 传导。本研究比较了通过附加射频应用消除潜伏性 PV 传导的 AF 消融患者与无传导患者的临床结果。
本研究共纳入 233 例连续接受 AF 消融的患者(206 例男性,54.2±10.1 岁)。在 PV 隔离后给予三磷酸腺苷诱发潜伏性 PV 传导,并通过补充射频应用消除。所有患者在第一次消融后均随访>12 个月(平均 903 天)。
在 233 例患者中,228 例(98%)在第一次消融过程中成功消除了腺苷诱导的潜伏性 PV 传导。在第一次消融后,149 例(63.9%)患者无 AF 复发事件。有或无潜伏性 PV 传导的患者单次或最终 AF 消融成功率相似(P=0.69 和 P=0.69)。
AF 患者中有一半以上出现潜伏性 PV 传导。消除三磷酸腺苷诱导的再连接后,有潜伏性 PV 传导的患者的临床结果与无传导患者相当。